PHARMACOKINETICS AND SPUTUM PENETRATION OF ENOXACIN AFTER TWICE DAILY ORAL DOSING FOR 7 DAYS

被引：9

作者：

DOBBS, BR ^{[1
]}

GAZELEY, LR ^{[1
]}

STEWART, IA ^{[1
]}

EDWARDS, IR ^{[1
]}

机构：

[1] UNIV OTAGO,SCH MED,DEPT SURG,DUNEDIN,NEW ZEALAND

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1988年 / 21卷

关键词：

D O I：

10.1093/jac/21.suppl_B.61

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：61 / 66

页数：6

共 12 条

[1] CROSS-RESISTANCE AMONG CINOXACIN, CIPROFLOXACIN, DJ-6783, ENOXACIN, NALIDIXIC-ACID, NORFLOXACIN, AND OXOLINIC ACID AFTER INVITRO SELECTION OF RESISTANT POPULATIONS [J].

BARRY, AL ;

JONES, RN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (06) :775-777

[2] COMPARATIVE INVITRO ACTIVITIES OF ENOXACIN (CI-919, AT-2266) AND 11 ANTIPSEUDOMONAL AGENTS AGAINST AMINOGLYCOSIDE-SUSCEPTIBLE AND AMINOGLYCOSIDE-RESISTANT PSEUDOMONAS-AERUGINOSA STRAINS [J].

BASSEY, CM ;

BALTCH, AL ;

SMITH, RP ;

CONLEY, PE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (03) :417-418

[3] PENETRATION OF CEFSULODIN INTO BRONCHIAL-SECRETIONS [J].

BERGOGNEBEREZIN, E ;

BERTHELOT, G ;

SAFRAN, D ;

EVEN, P ;

KAFE, H .

CHEMOTHERAPY, 1984, 30 (04) :205-210

[4] COMPARATIVE INVITRO ACTIVITIES OF 10 ANTI-MICROBIAL AGENTS AGAINST BACTERIAL ENTEROPATHOGENS [J].

CARLSON, JR ;

THORNTON, SA ;

DUPONT, HL ;

WEST, AH ;

MATHEWSON, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :509-513

[5] SERUM AND SPUTUM CONCENTRATIONS OF ENOXACIN AFTER SINGLE ORAL DOSING IN A CLINICAL AND BACTERIOLOGICAL STUDY [J].

DAVIES, BI ;

MAESEN, FPV ;

TEENGS, JP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 :83-89

[6] NALIDIXIC-ACID RESISTANCE - 2ND GENETIC CHARACTER INVOLVED IN DNA GYRASE ACTIVITY [J].

GELLERT, M ;

MIZUUCHI, K ;

ODEA, MH ;

ITOH, T ;

TOMIZAWA, JI .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (11) :4772-4776

[7]

LAM FC, 1983, BIOMETRIKA, V70, P510

[8]

PUCHELLE E, 1984, J LAB CLIN MED, V103, P347

[9]

RUDRIK JT, 1984, ANTIMICROB AGENTS CH, V26, P97, DOI 10.1128/AAC.26.1.97

[10]

SELWYN S, 1984, DRUG EXP CLIN RES, V10, P653

← 1 2 →